Abstract:Ethnopharmacological relevance: Baicalein (B), a bioactive flavone isolated from the root of a traditional Chinese medicinal herb Scutellaria baicalensis Georgi, was found to undergo extensive intestinal Phase II metabolism during its absorption process. Compounds sharing the same metabolic pathways with B or being inhibitors of enzymes UGT and SULT are expected to interfere with the metabolism of B leading to alteration of the absorption of B. The present study aims to identify potential intestinal absorption and metabolism interactions between B and four selected compounds, namely acetaminophen (APAP), (-)-epicatechin (EC), piperine (PIP) and curcumin (CUR) using in vitro and in situ models.Materials and methods: Three in vitro and one in situ methods were employed to investigate the effect of selected compounds on the metabolism and absorption on B. Incubation studies using rat intestinal s9 and Caco-2 cell lysate were used to study the effect of selected compounds on glucuronidation and sulfation of B. Sigmoidal dose-response curves were plotted and IC50 values were estimated. Apical to basolateral absorption study using Caco-2 cell monolayer model was also employed to study the effect of selected compounds on absorption of B. The most potent inhibitor identified was selected to further investigate its potential herb-drug interaction with B using in situ rat intestinal perfusion model. LC/MS/MS was used for the analysis of B and its metabolites in collected samples.Results: It was found that all the four selected compounds could produce a dose-dependent inhibition on the glucuronidation and sulfation of B. Moreover, the presence of CUR and high-dose EC demonstrated a subsequent increase in the absorption of B. In general, the order of potency on glucuronidation inhibition is: CUR > PIP > EC > APAP; while the potency order on sulfation inhibition is: CUR > EC > PIP > APAP. CUR was selected to further study its in vivo effect on B using in situ rat intestinal perfusion model. It was found that CUR could significantly increase the absorption of B via the inhibition on formation of its metabolites.Conclusions: Our findings indicated that the intestinal metabolism of B could be inhibited by all the selected compounds with CUR being the most potent inhibitor, which could result in subsequent increase of absorption of B. The current study had significant implications for further investigation on the in vivo evaluations of the herb-drug and herb-herb interactions between B and selected compounds, especially CUR. (C) 2011 Elsevier Ireland Ltd. All rights reserved.

Preparation, Characterization and in Vivo Evaluation of Formulation of Baicalein with Hydroxypropyl-Beta-Cyclodextrin

Preparation and characterization of inclusion complexes formed between baicalein and cyclodextrins.

Preparation and Characterization of Baicalein/hydroxypropyl-Β-cyclodextrin Inclusion Complex for Enhancement of Solubility, Antioxidant Activity and Antibacterial Activity Using Supercritical Antisolvent Technology

Hepatic Metabolism and Disposition of Baicalein via the Coupling of Conjugation Enzymes and Transporters— In Vitro and In Vivo Evidences

Preparation of baicalein solid dispersions and oral bioavailability in rats

Preparation, pharmacokinetics and biodistribution of baicalin-loaded liposomes

Enhancing The Oral Bioavailability Of Baicalein Via Solutola (R) Hs15 And Poloxamer 188 Mixed Micelles System

Preparation, optimization, characterization and in vitro release of baicalein-solubilizing glycyrrhizic acid nano-micelles

Physicochemical Characterization and Pharmacokinetics Evaluation of Β-Caryophyllene/β-cyclodextrin Inclusion Complex.

Preparation and Characterization of Baicalein Powder Micronized by the SEDS Process

A Strategy to Improve the Oral Availability of Baicalein: the Baicalein-Theophylline Cocrystal.

Preparation, Characterization, Solubilization and Antioxidant Activity of Polyamine Modified Β-Cyclodextrins with Baicalein Inclusion Complexes

Investigation of the Improved Effects of 2-Hydroxypropyl-β-cyclodextrin on Solubility, Dissolution Rate, and Intestinal Absorptive Profile of Tanshinone IIA in Rats

Preparation of β-cyclodextrin and hydroxypropyl-β-cyclodextrin inclusion complexes of baicalein and evaluation of their effects on dextran sulfate sodium-induced acute ulcerative colitis in mice

Evaluation on preparation process of baicalin-Eudragit L100-55 enteric coated solid dispersion and its in vitro release

Complexation of Tanshinone IIA with 2-Hydroxypropyl-β-cyclodextrin: Effect on Aqueous Solubility, Dissolution Rate, and Intestinal Absorption Behavior in Rats

The Formation Of A Host-Guest Inclusion Complex System Between -Cyclodextrin And Baicalin And Its Dissolution Characteristics

Nanostructured Lipid Carriers for Oral Delivery of Baicalin: in Vitro and in Vivo Evaluation

Improved Bioavailability and Hepatoprotective Activity of Baicalein Via a Self-assembled Solutol HS15 Micelles System

In Vitro and in Situ Evaluation of Herb–drug Interactions During Intestinal Metabolism and Absorption of Baicalein

Preparation and evaluation of self-microemulsifying drug delivery system of baicalein